Diabetic retinopathy (DR) is the commonest microvascular complication of diabetes and remains one of the leading causes of blindness worldwide among adults aged 20–74 years. Understanding the molecular mechanisms involved in the development and progression of diabetic retinopathy is important to identify novel therapeutic targets for therapy. We invite submissions of original research or review articles on pathophysiologic mechanisms involved in the development and progression of diabetic retinopathy. Moreover, papers dealing with new methods of imaging and treating diabetic retinopathy would be of great interest. Potential topics include, but are not limited to:

• Inflammation in diabetic retinopathy
• Angiogenic and fibrogenic factors in diabetic retinopathy
• Neurodegeneration in diabetic retinopathy
• Role of vasculogenesis in diabetic retinopathy
• Glial cell activation in diabetic retinopathy
• Oxidative stress in diabetic retinopathy
• Imaging techniques in diabetic retinopathy
• New methods of treating diabetic retinopathy

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/edr/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/author/submit/journals/edr/mdr/ according to the following timetable: